| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Comprehensive Lipid Management Versus Aggressive Low-Density Lipoprotein Lowering to Reduce Cardiovascular Risk
|
Knopp, Robert H.
|
|
2008
|
101 |
8S |
p. S48-S57
10 p.
|
artikel
|
| 2 |
Evidence to Support Aggressive Management of High-Density Lipoprotein Cholesterol: Implications of Recent Imaging Trials
|
Taylor, Allen J.
|
|
2008
|
101 |
8S |
p. S36-S43
8 p.
|
artikel
|
| 3 |
Faculty Disclosures
|
|
|
2008
|
101 |
8S |
p. viii-ix
nvt p.
|
artikel
|
| 4 |
Faculty List
|
|
|
2008
|
101 |
8S |
p. vi-vii
nvt p.
|
artikel
|
| 5 |
Introduction
|
Davidson, Michael H.
|
|
2008
|
101 |
8S |
p. S1-S2
2 p.
|
artikel
|
| 6 |
Mechanism of Action of Niacin
|
Kamanna, Vaijinath S.
|
|
2008
|
101 |
8S |
p. S20-S26
7 p.
|
artikel
|
| 7 |
Niacin and Lipoprotein(a): Facts, Uncertainties, and Clinical Considerations
|
Scanu, Angelo M.
|
|
2008
|
101 |
8S |
p. S44-S47
4 p.
|
artikel
|
| 8 |
Niacin Use and Cutaneous Flushing: Mechanisms and Strategies for Prevention
|
Davidson, Michael H.
|
|
2008
|
101 |
8S |
p. S14-S19
6 p.
|
artikel
|
| 9 |
Nicotinic Acid, Alone and in Combinations, for Reduction of Cardiovascular Risk
|
Brown, B. Greg
|
|
2008
|
101 |
8S |
p. S58-S62
5 p.
|
artikel
|
| 10 |
Reducing the Residual Risk of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor Therapy With Combination Therapy
|
Polonsky, Tamar S.
|
|
2008
|
101 |
8S |
p. S27-S35
9 p.
|
artikel
|
| 11 |
Safety of Niacin and Simvastatin Combination Therapy
|
Bays, Harold
|
|
2008
|
101 |
8S |
p. S3-S8
6 p.
|
artikel
|
| 12 |
The Safety of Niacin in the US Food and Drug Administration Adverse Event Reporting Database
|
Alsheikh-Ali, Alawi A.
|
|
2008
|
101 |
8S |
p. S9-S13
5 p.
|
artikel
|
| 13 |
Title Page
|
|
|
2008
|
101 |
8S |
p. i-
1 p.
|
artikel
|
Tijdschrift beschrijving